HHV8 ORF50 anticorps (AA 2-100) (Biotin)

N° du produit ABIN672683

Détail du produit anti-HHV8 ORF50 anticorps (Biotin)

Antigène: HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))

Épitope: AA 2-100

Reactivité: Human Herpesvirus 8 (HHV-8), Virus

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HHV8 ORF50 est conjugé à/à la Biotin

Application: Western Blotting (WB)

Réactivité croisée: Virus

Réactivité croisée (Details): Human herpesvirus 8, Kaposi's sarcoma-associated herpesvirus

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from N-terminus of HHV8 ORF50 strain GK18

Isotype: IgG

Information d'application

Indications d'application: IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur HHV8 ORF50

Antigène: HHV8 ORF50 (Herpes Virus Type 8 ORF50 (HHV8 ORF50))

Autre désignation: HHV8 ORF50 (HHV8 ORF50 Produits)

Classe de substances: Viral Protein

Sujet:

Synonyms: HHV 8, Human Herpes Virus 8, Human herpesvirus 8, HHV8 ORF50, Kaposi's sarcoma associated herpes virus, Kaposi's sarcoma associated herpesvirus, KSHV, replication and transcription activator, RTA

Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.

ID gène: 4961526

UniProt: F5HCV3